On June 29th, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted a webinar entitled “Key Factors for Successful Uptake of Biosimilars: Europe and the US: measures taken for improving biosimilar uptake and the potential role of healthcare providers and patients”. The event featured a keynote presentation by former U.S. Deputy Secretary of Health and Human Services Eric David Hargan.
Other speakers at the two-hour event included:
- Michael S Reilly, Esq, Executive Director, Alliance for Safe Biologic Medicines
- Ralph McKibbin, MD, FACP, FACG, AGAF, Pennsylvania Society of Gastroenterology/Digestive Disease National Coalition
- Professor Philip J Schneider, MS, FASHP, FASPEN, FFIP, Ohio State University College of Pharmacy
- Chad Pettit, MBA, Global Biosimilars Commercial Lead, Amgen
- Andrew Spiegel, Esq, Global Colon Cancer Association
The event concluded with a panel discussion and Q&A session between participants, hosted by federal health policy expert Steven Stranne, MD, JD.
You can watch the replay of the webinar here, and the speaker presentations are available here.
The discussion will continue at the next webinar on “Non-medical switching of biologicals/biosimilars: Canada, Europe, the US” on July 20, 2022.
